Suzhou Basecare Medical Corporation Limited (HKG:2170)
Hong Kong · Delayed Price · Currency is HKD 1.920
-0.030 (-1.54%)
Feb 11, 2026, 3:46 PM HKT
HKG:2170 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 275.71 | 299.11 | 207.98 | 140.9 | 107.3 | 81.11 | |
Revenue Growth (YoY) | 11.55% | 43.82% | 47.60% | 31.32% | 32.29% | 45.66% |
Cost of Revenue | 144.17 | 162.89 | 116.63 | 81.37 | 56.15 | 53.4 |
Gross Profit | 131.54 | 136.22 | 91.35 | 59.53 | 51.15 | 27.71 |
Selling, General & Admin | 272.42 | 276.39 | 209.3 | 161.5 | 114.64 | 41.86 |
Research & Development | 122.43 | 135.26 | 129.57 | 119.77 | 73.71 | 34.48 |
Other Operating Expenses | -6.38 | -7.63 | -5.85 | -5.7 | -4.82 | 5.46 |
Operating Expenses | 388.48 | 404.01 | 333.02 | 275.57 | 183.53 | 81.81 |
Operating Income | -256.94 | -267.79 | -241.67 | -216.04 | -132.38 | -54.09 |
Interest Expense | -12.87 | -9.37 | -2.61 | -0.5 | -1.26 | -1.47 |
Interest & Investment Income | 16.75 | 25.27 | 38.51 | 23.62 | 18.2 | 0.52 |
Earnings From Equity Investments | - | - | - | - | - | 0.25 |
Currency Exchange Gain (Loss) | 6.03 | 8.66 | 11.86 | 62.91 | -10.31 | - |
Other Non Operating Income (Expenses) | - | - | - | - | - | -826.83 |
EBT Excluding Unusual Items | -247.03 | -243.24 | -193.92 | -130.01 | -125.75 | -881.62 |
Gain (Loss) on Sale of Investments | 5 | 2.9 | -2.4 | 3.4 | - | 0.1 |
Pretax Income | -242.03 | -240.34 | -196.32 | -126.61 | -125.75 | -881.52 |
Income Tax Expense | -3.25 | -3.13 | -2.97 | 6.01 | 18.33 | -7.39 |
Earnings From Continuing Operations | -238.79 | -237.21 | -193.35 | -132.63 | -144.08 | -874.12 |
Earnings From Discontinued Operations | - | - | - | 9.12 | - | -2.93 |
Net Income to Company | -238.79 | -237.21 | -193.35 | -123.51 | -144.08 | -877.05 |
Minority Interest in Earnings | 0.19 | 0.18 | 1.66 | 0.84 | 0.43 | - |
Net Income | -238.59 | -237.03 | -191.69 | -122.66 | -143.65 | -877.05 |
Net Income to Common | -238.59 | -237.03 | -191.69 | -122.66 | -143.65 | -877.05 |
Shares Outstanding (Basic) | 274 | 274 | 274 | 274 | 265 | 172 |
Shares Outstanding (Diluted) | 274 | 274 | 274 | 274 | 265 | 172 |
Shares Change (YoY) | - | - | - | 3.09% | 54.34% | 16.39% |
EPS (Basic) | -0.87 | -0.87 | -0.70 | -0.45 | -0.54 | -5.10 |
EPS (Diluted) | -0.87 | -0.87 | -0.70 | -0.45 | -0.54 | -5.10 |
Free Cash Flow | -297.35 | -322.41 | -371.44 | -317.22 | -226.75 | -72.38 |
Free Cash Flow Per Share | -1.09 | -1.18 | -1.36 | -1.16 | -0.85 | -0.42 |
Gross Margin | 47.71% | 45.54% | 43.92% | 42.25% | 47.67% | 34.17% |
Operating Margin | -93.19% | -89.53% | -116.20% | -153.33% | -123.38% | -66.69% |
Profit Margin | -86.54% | -79.25% | -92.17% | -87.06% | -133.88% | -1081.33% |
Free Cash Flow Margin | -107.85% | -107.79% | -178.60% | -225.14% | -211.33% | -89.23% |
EBITDA | -219.69 | -237.6 | -227.18 | -210.59 | -129.5 | -48.99 |
EBITDA Margin | -79.68% | -79.44% | -109.23% | -149.46% | -120.69% | -60.40% |
D&A For EBITDA | 37.25 | 30.19 | 14.49 | 5.45 | 2.89 | 5.1 |
EBIT | -256.94 | -267.79 | -241.67 | -216.04 | -132.38 | -54.09 |
EBIT Margin | -93.19% | -89.53% | -116.20% | -153.33% | -123.38% | -66.69% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.